Warnings Headlines

  • Austria wants EU leaders to agree on strengthening Frontex in September

    VIENNA (Reuters) - Austria's Chancellor Sebastian Kurz hopes that European Union leaders will reach an agreement on strengthening the border agency Frontex at an informal meeting in September, he told the newspaper Der Standard.

    www.reuters.com
  • AT&T CEO says ready to invest, WarnerMedia rebranding unveiled

    (Reuters) - AT&T Inc is committed to spend as much as needed on the media business of newly acquired Time Warner Inc , Chief Executive Randall Stephenson told CNBC on Friday, with a plan to invest $21 billion to $22 billion in the combined company.

    in.reuters.com
  • AT&T CEO says ready to invest, WarnerMedia rebranding unveiled

    (Reuters) - AT&T Inc is committed to spend as much as needed on the media business of newly acquired Time Warner Inc, Chief Executive Randall Stephenson told CNBC on Friday, with a plan to invest $21 billion to $22 billion in the combined company.

    in.reuters.com
  • AT&T CEO says ready to invest, WarnerMedia rebranding unveiled

    (Reuters) - AT&T Inc is committed to spend as much as needed on the media business of newly acquired Time Warner Inc, Chief Executive Randall Stephenson told CNBC on Friday, with a plan to invest $21 billion to $22 billion in the combined company.

    www.reuters.com
  • AT&T CEO says ready to invest, WarnerMedia rebranding unveiled

    (Reuters) - AT&T Inc is committed to spend as much as needed on the media business of newly acquired Time Warner Inc, Chief Executive Randall Stephenson told CNBC on Friday, with a plan to invest $21 billion to $22 billion in the combined company.

    www.reuters.com
  • Novartis touts effectiveness, safety of autoimmune drug copies

    ZURICH (Reuters) - Novartis on Friday touted safety and efficacy of its biosimilar copies of Johnson & Johnson's Remicade and Amgen Inc's Enbrel, citing a study it hopes will help convince doctors that switching from the original medicines is a viable alternative for treating autoimmune diseases.

    in.reuters.com